| Q37332868 | Antiretroviral bioanalysis methods of tissues and body biofluids |
| Q34768558 | Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. |
| Q33405725 | Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy |
| Q35641179 | Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy |
| Q28085028 | Efavirenz and the CNS: what we already know and questions that need to be answered |
| Q34219621 | Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells |
| Q58815131 | Genital shedding of HIV after scheduled treatment interruption |
| Q34389260 | HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapy |
| Q73185154 | Lopinavir/ritonavir: a review of its use in the management of HIV infection |
| Q33888718 | Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention |
| Q35548422 | The male genital tract is not a pharmacological sanctuary from efavirenz. |
| Q37200979 | Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy |